Andrew

Important Kratom Legislative Updates: February 2021

Kratom has received plenty of attention across state legislatures this month. Below is a rundown of all that has taken place in the US kratom sphere since the beginning of February.  Mississippi Back in early January, a Mississippi Senate Bill was proposed calling to add kratom to Schedule I of the Uniform Controlled Substance Act. …

Important Kratom Legislative Updates: February 2021 Read More »

Federal Research on Kratom Granted for 2021

The United States House Committee on Appropriations has allocated the Agency for Healthcare Research and Quality (AHRQ) $500,000 towards kratom research for the year of 2021. The AHRQ was given a budget of $338,000,000 in total. “The Committee is aware of the potential promise of kratom-derived compounds for acute and chronic pain patients who seek safer …

Federal Research on Kratom Granted for 2021 Read More »

Idaho’s Controversial New Amendment

What a busy start to 2021. On Friday, January 29, the Idaho Senate committee will meet to vote on an anti-drug constitutional amendment. Specifically, the Senate Joint Resolution No. 101 will ban, “the production, manufacture, transportation, sale, delivery, dispensing, distribution, possession, or use of psychoactive drugs in the state of Idaho.” The amendment is significant …

Idaho’s Controversial New Amendment Read More »

Why the AHRQ Review On Chronic Pain Matters

December 2020 The Agency for Healthcare and Research Quality (AHRQ) is currently conducting a systematic review on plant-based treatment for chronic pain. Their goal: “identify alternative treatments (to opioids) with equal or better benefits for pain while avoiding potential unintended consequences.” Specifically, they will be reviewing the benefits and potential harms of cannabinoids and kratom. …

Why the AHRQ Review On Chronic Pain Matters Read More »